Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 11:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 793–816 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Diabetes, Schizophrenia, Insulin Resistance, Cognitive Impairment
Interventions: Pioglitazone, Life style diet group, Placebo; Drug · Behavioral · Other
Lead sponsor: Nathan Kline Institute for Psychiatric Research; Other
Eligibility: 18 Years to 70 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Mild Cognitive Impairment, Aortic Stenosis
Interventions: 5 minute Montreal Cognitive Assessment (mini MoCA); Other
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 4
States / cities: Dallas, Texas • Fort Worth, Texas • Plano, Texas + 1 more

Conditions: Back Pain
Interventions: SIJ pain diagnostic tests; Other
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 64 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Chronic Granulomatous Disease (CGD), X-Linked Severe Combined Immune Deficiency (XSCID), Leukocyte Adhesion Deficiency 1 (LAD), Graft Versus Host Disease (cGvHD)
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: Not listed
Enrollment: 3,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mild Cognitive Impairment
Interventions: Patient Survey, Mini Cog, Independent Activities of Daily Living Score Sheet, Activities of Daily Living Score Sheet, Geriatric Depression Scale Short Form, Confusion Assessment Method (CAM), RAND 36-Item Short Form Health Survey, Grip Strength; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 65 Years and older
Enrollment: 711 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Congenital Heart Disease, Bradycardia Sinus
Interventions: Closed loop stimulation, Standard rate response; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 14 Years to 65 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Preeclampsia
Interventions: Salsalate Oral Tablet, Placebo Oral Tablet; Drug
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years and older · Female only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 2
States / cities: Iowa City, Iowa • University Park, Pennsylvania

Conditions: Spinal Cord Injury, Spinal Cord Involvement, Spina Bifida, Transverse Myelitis, Polio and Post-polio Syndrome, Syringomyelia, Spinal Stenosis, Spinal Neoplasms, Spinal Cord Diseases
Interventions: SCI Hard; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 13 Years to 29 Years
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Secondary Hypogonadism, Sexual Dysfunction, Erectile Dysfunction
Interventions: fispemifene, Placebo; Drug · Other
Lead sponsor: NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.); Industry
Eligibility: 18 Years to 64 Years · Male only
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 16
States / cities: Little Rock, Arkansas • San Diego, California • Bradenton, Florida + 12 more

Conditions: Heart Failure, Left Ventricular Dysfunction, Cardiac Resynchronization Therapy
Interventions: Guided, Non-guided; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2018
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Evaporative Dry Eye Disease, Meibomian Gland Dysfunction
Interventions: ELM; Device
Lead sponsor: Eyedetec Medical, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Citrus Heights, California

Conditions: Carcinoma, Hepatocellular
Interventions: Brivanib; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 4
States / cities: Birmingham, Alabama • Los Angeles, California • Clleveland, Ohio + 1 more

Conditions: Sexual Dysfunction, Physiological, Sexual Dysfunctions, Psychological
Interventions: Physical activity; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years and older · Female only
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Breast Cancer, Cognitive/Functional Effects, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults
Interventions: assessment of therapy complications, cognitive assessment, fatigue assessment and management; Procedure
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: Cleveland, Ohio

Conditions: Alzheimer Disease
Interventions: PQ912, Placebo; Drug · Other
Lead sponsor: Vivoryon Therapeutics N.V.; Industry
Eligibility: 50 Years to 89 Years
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 22
States / cities: Phoenix, Arizona • Sun City, Arizona • Chula Vista, California + 19 more

Conditions: Larynx Stenosis, Larynx Disease, Laryngectomy, Larynx, Larynx Fracture
Interventions: Larynx Allograft Transplantation; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2033
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Drug Toxicity
Interventions: Placebo, MW151, 10mg, MW151, 20mg, MW151, 40mg, MW151, 80mg, MW151, 160mg; Drug
Lead sponsor: Linda Van Eldik; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Gastrointestinal Dysfunction
Interventions: PreforPro+B. subtilis DE111 probiotics, Placebo, B. subtilis DE111; Dietary Supplement
Lead sponsor: Colorado State University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: HIV Infection, Hepatitis C
Interventions: nelfinavir 1,250 mg twice daily, Zidovudine 300 mg twice daily, Lamivudine 150 mg twice daily; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 4
States / cities: Bakersfield, California • Miami, Florida • Shreveport, Louisiana + 1 more

Conditions: Endothelial Dysfunction
Interventions: Aliskiren, Placebo; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Spinal Cord Injury, Bladder Dysfunction
Interventions: Not listed
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 64 Years · Male only
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2010
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Type 2 Diabetes
Interventions: High intensity aerobic interval training, Continuous moderate intensity exercise; Other
Lead sponsor: University of Florida; Other
Eligibility: 30 Years to 79 Years
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Neoplasms
Interventions: ABT-888, Carboplatin, Paclitaxel; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 110 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 2
States / cities: Bethesda, Maryland • Pittsburgh, Pennsylvania

Conditions: Cancer of the Prostate, Cancer
Interventions: Cognitive Remediation Therapy; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: West Haven, Connecticut

Search by objective public record fields.

Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia

Prospective Evaluation of Neurocognition in Patients Undergoing Transcatheter Aortic Valve Replacement

IRB-HSR # 14073 Investigation of Pelvic Girdle Dysfunction in the Low Back Pain Population

Evaluation of Patients With Immune Function Abnormalities

Preoperative Cognitive Screening of Surgical Patients 65 Years of Age or Older

Specialized Pacing for Patients With Congenital Heart Disease

Angiotensin II and Chronic Inflammation in Persistent Microvascular Dysfunction Following Preeclampsia

Clinical Trial of a Serious Game for Individuals With SCI/D

Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men

Use of 3-D Blood Pool Scintigraphy to Guide Left Ventricular Pacing Lead Placement in Patients Requiring Cardiac Resynchronization Therapy

Clinical Study Using Eye Lipid Mobilizer (ELM) With Heat and Vibration To Treat Evaporative Dry Eye Disease

A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction

Sexual Health on Antidepressants Through Physical Exercise

Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers

A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD

Laryngeal Allograft Transplantation

MW151-101: First-in-human Study of MW151

Phage 3Determination of Phage/Probiotic Synergistic Effects on Gastrointestinal Health

An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C

The Effect of Tekturna on Endothelial Function and Endothelial Progenitor Cells in Patients With Early Atherosclerosis

Quantitative and Qualitative Changes in Neural Efferent Receptors

Effect of Aerobic Interval Training on Cardiovascular Function in Type 2 Diabetes

ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems

Cognitive Remediation Therapy (CRT) for Adults Treated for Cancer